AACC 2022 Chicago: What to Expect
2022 AACC Annual Scientific Meeting & Clinical Lab Expo
On-site experience
Meet us in Chicago!
Mark your calendars and meet us in Chicago to exchange ideas on industry-leading solutions that can improve operational efficiency and enhance clinical insight at every opportunity, allowing you to push the boundaries of what’s possible in diagnostics.
Interested in a personalized booth tour? Reach out to your Siemens Healthineers representative or visit our welcome desk to schedule one.
Register today for access and to stay up-to-date on events at the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo
Schedule of Events
All times in CDT (Central Daylight Time)
Sunday July 24 - Monday July 25
The 2022 AACC Annual Scientific Meeting & Clinical Lab Expo opens. Enjoy plenary sessions, scientific sessions, and roundtables hosted throughout McCormick Place in Chicago.
Tuesday, July 26
Booth hours: 9:30 a.m. to 5:00 p.m.
Wednesday, July 27
Booth hours: 9:30 a.m. to 5:00 p.m.
Thursday, July 28
Booth hours: 9:30 a.m. to 1:00 p.m.
Learn @AACC
Educational Offerings
Visit our industry workshop and scientific poster sessions at AACC 2022, where our distinguished scientists will present on a variety of topics.
Hotel Industry Workshop
From Increased Risk to Modified Management: Unmasking How the Coronavirus Pandemic has Affected Diabetes Care
The post-infection consequences of COVID-19 are only starting to be fully realized. Multiple recent publications have shown strong evidence that there is a link between COVID-19 and an increased risk of developing and unmasking diabetes intra- and post infection*. Join us for an in-depth conversation with industry experts as we discuss the broad implications of this trend.
Presented by our Expert Panel:
Location:
Marriott Marquis – Grand Horizon Ballroom EF
*Sources available on request
Scientific Posters: Laboratory Diagnostics
Poster # | Title | Authors (presenters in bold) |
A-011 | Performance Evaluation of the Atellica CH 930 Analyzer Lac_3, CHE_2, and Hapt_2 Assays | Cheek J, Thomas J, Blagovcanin D, Sinopoli A, Johnson T, O’Brien J |
A-038 | Performance Evaluation of the Dimension EXL LOCI BRAHMS PCT Assay | Walters A, Israel B, Kelly K, Schaible C, Tyler A, Wei T. |
A-068 | Performance Characteristics of the Thyroid Stimulating Hormone 3 Ultra Assay on the Atellica® CI 1900* Analyzer | Quintanilla M, Zhang H, Leipold H, Coladangelo M, Philippe N, Brescia K |
B-028 | Performance Evaluation of the Newly Developed N Latex aTNFα Reagent for Quantification of the TNFα Inhibitors Adalimumab, Infliximab, and Etanercept Using Automated Siemens Healthineers Immunonephelometry Systems | Freidel C, Mueller L, Weisspflug E, Schelp C |
B-060 | Performance Evaluation of the High-sensitivity ADVIA Centaur and Atellica IM Serum Neurofilament Light Chain (sNfL) Assay | Merabet E, Meenan J. |
A-065 | Performance Evaluation of the ADVIA Centaur® NT-proBNPII (PBNPII) Assay | Farnsworth C, Januzzi J, Privon G, Schiavoni L, Diemer K, Rigler J, Plouffe B, Miller E, Bermel S, Brown C, Liu Y, Gartland A, Nissen K. |
B-169 | An Algorithm to Predict COVID-19 Positivity Using Hematology Data from the ADVIA 2120i Hematology System. | Gupta K, Mitra N, Jones V, Gibbs G, Stelling F, Chaves F. |
B-136 | A Clinical Decision System Using Deep Learning for Accurate and Timely Sepsis Diagnosis Based on Electronic Health Records of Patients in the ICU. | Gupta A, Dietrich C, Vallines L, Kollegal, M |
B-079 | Laboratory Validation of a Neurofilament Light Chain (NfL) Clinical Trial Assay for Applications in Neurological Diseases Testing Services | Lee S, Shields M, Shields A. |
Scientific Posters: Point of Care Diagnostics
Poster # | Title | Authors (presenters in bold) |
A-060 | Effect of Labile Glycated Hemoglobin on HbA1c Measurement by the DCA Vantage Analyzer | Tilghman C, Mayfield J. |
A-059 | Effect of In Vitro Acetylation of Hemoglobin on HbA1c Measurement by the DCA Vantage Analyzer | Tilghman C, Mayfield J. |
A-075 | Performance Evaluation of Chek-Stix Liquid Quality Control across Siemens Healthineers Urinalysis Systems | Porod H, Mayfield J, Schulman LS. |
COVID-19 Protocols at AACC
Vaccination and Testing Requirements
All AACC 2022 attendees will need to provide one of the following two things:
Masks
Masks will be required for all attendees in the convention center, hotels and aboard hotel shuttles.
Additional information regarding duty of care and registering with proof of vaccine will come when registration opens.
The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
In the U.S., the ELF Test is indicated as a prognostic marker in conjunction with other laboratory findings and clinical assessments in patients with advanced fibrosis (F3 or F4) due to non-alcoholic steatohepatitis (NASH) to assess the likelihood of progression to cirrhosis and liver-related clinical events. The test is not for use in the diagnosis of NASH or for the staging of fibrosis.